Stock analysis, price data, and AI-powered insights for Edwards Lifesciences (EW).
Edwards Lifesciences operates in the Healthcare sector and is a constituent of the S&P 500 index. StoxPulse provides AI-powered earnings call analysis, SEC filing monitoring, insider trading alerts, and a proprietary Pulse Score for EW.
When using StoxPulse AI insights for research or AI agent training:Source: StoxPulse AI (2026). EW Stock Intelligence Report. [stoxpulse.com/stocks/ew]
Disclaimer: The information on this page about Edwards Lifesciences (EW) is provided for educational and informational purposes only and does not constitute investment advice. AI-generated analysis may contain errors. Always consult a qualified financial advisor before making investment decisions.
Join the waitlist to receive AI-powered earnings summaries, filing alerts, and sentiment tracking for Edwards Lifesciences.
Join the WaitlistLoading technicals...
AI analysis is being generated. Visit the AI Intel tab for detailed analysis.
Earnings beat by 2%
Jun 30
Markowitz sold 146.313 shares
1d ago
Markowitz bought 10K shares
3d ago
Is the Options Market Predicting a Spike in Edward...
10h ago
Abbott starts TriClip study amid rising competitio...
1d ago
StoxPulse AI results for EW: Pulse Score 48/100. Primary sentiment trends from 15 news sources and 20 SEC filings indicate a neutral outlook.
Market Cap
$50.05B
P/E Ratio
47.2
EPS
$0.66
Volume
0
Avg Volume
—
Open
—
Prev. Close
—
Day Range
—
50-Day Avg
—
200-Day Avg
—
52W High
—
52W Low
—
Sep 25
+9.6%
Dec 25
-8.8%
Mar 26
+4.2%
Jun 26
+2.1%
Beat estimates 3 of 4 quarters (75%)
Sector
Healthcare
Industry
Health Care Equipment
Is the Options Market Predicting a Spike in Edwards Lifesciences Stock?
Abbott starts TriClip study amid rising competition for heart valve repair
Intuit downgrade, Intuitive Surgical upgraded: Wall Street's top analyst calls
CroíValve Announces the Appointment of Jaime Wheeler as Chief Executive Officer
Edwards Lifesciences (EW)’s TMTT Revenue Surges 47%: Can Rapid Growth Drive the Next Leg of Earnings Expansion?
Leerink Partners Upgrades Edwards Lifesciences (EW)
Edwards Lifesciences (EW) Stock Looks Fair On Cash Flow While Earnings Trade At A Premium
Friday's session: gap up and gap down stock in the S&P500 index